Governance Classic Home
Neuland Laboratories LtdPharmaceuticalsINE794A01010Consolidated₹19614.30+179.10 (+0.92%)
Valuation
Market Cap₹25.12K Cr
TTM PE55.50x
Forward PE45.72x
PEG-6.11
Book Value₹1461.02
P/B13.40x
TTM EPS₹352.72
Fwd EPS₹428.13
TTM Revenue₹2.31K Cr
TTM PAT₹452.54 Cr
TTM EBITDA₹704.93 Cr
TTM EBIT₹600.59 Cr
Last Qtr PAT₹51.63 Cr
Last Qtr EBITDA₹97.57 Cr
Last Qtr EBIT₹68.80 Cr
Profitability
ROE24.14%
ROCE30.54%
TTM NPM19.61%
TTM EBITDA %30.55%
Curr OPM11.29%
Last OPM22.72%
Curr NPM—
Last NPM—
Curr EPS₹40.24
Last EPS₹115.10
Balance sheet
Equity₹12.90 Cr
Reserve₹1.86K Cr
Total Debt₹211.62 Cr
D/E0.11x
Interest %14.16%
Curr Interest₹7.31 Cr
Price / range
Close₹19576.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.78%
1W-2.01%
1M-8.75%
3M+1.69%
6M+21.56%
1Y+11.19%
2Y+32.88%
3Y+407.07%
5Y+1059.27%
Diwali+29.48%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue449.66-12.6%641.58776.25439.71514.272,022.99
Other Income7.498.4912.468.051.8030.16
Total Income457.15-11.4%650.07788.71447.76516.072,053.15
Interest7.316.977.236.795.3423.95
Expenditure-388.67-0.4%-452.53-501.66-393.49-387.03-1,565.42
PBDT000000
EBITDA97.07-37.4%222.58306.9176.93155.12573.25
Depreciation-28.77-26.56-25.09-23.92-22.54-91.73
EBIT68.30-48.5%196.02281.8253.01132.58481.52
PBT68.48-46.9%197.54287.0454.27129.04487.73
Tax-17.35-50.17-74.52-13.86-32.58-124.63
Equity12.9012.9012.9012.90012.90
OPM14.9830.3936.3912.1225.0923.76
Net Profit51.13-47.0%147.36212.5240.4296.46363.11
NPM11.1822.6726.959.0318.7617.69
EPS39.85-47.0%114.86165.6531.5075.18283.01

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,022.99+37.0%1,476.84-5.2%1,558.58+30.8%1,191.20+25.2%951.08+1.5%936.91
Other Income30.1620.5112.549.752.0816.10
Total Income2,053.15+37.1%1,497.35-4.7%1,571.13+30.8%1,200.95+26.0%953.15+0.0%953.01
Expenditure-1,565.42-27.4%-1,228.38-5.0%-1,170.36-18.7%-985.73-13.1%-871.41-2.8%-848.05
Interest-23.95-8.30-14-13.07-13.49-17.90
PBDT000000
EBITDA573.25+77.9%322.30-30.2%461.92+70.2%271.32+90.8%142.20-2.9%146.44
Depreciation-91.73-65.54-59.70-52.78-49.04-39.68
EBIT481.52+87.5%256.76-36.2%402.22+84.0%218.54+134.6%93.16-12.7%106.76
PBT487.73+41.2%345.37-13.8%400.77+86.2%215.21+163.3%81.74-22.1%104.96
Tax-124.63-85.95-101.17-52.09-18.21-24.67
Equity12.9012.900000
OPM (%)23.7623.0726.0018.009.0011.00
Net Profit363.11+40.0%259.43-13.4%299.60+83.7%163.12+156.8%63.53-20.9%80.30
NPM (%)17.6917.3319.0014.007.008.00
EPS (Rs)283.01+40.0%202.20-13.4%233.51+83.7%127.14+156.7%49.52-20.9%62.58
CEPS283.01202.20233.51127.1449.5262.58

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue449.66-12.6%641.58776.25439.71514.272,022.99
Other Income7.508.4912.468.051.8030.17
Total Income457.15-11.4%650.07788.71447.76516.072,053.15
Interest7.316.977.216.795.3723.95
Expenditure-388.17-0.4%-452.22-501.21-393.29-386.64-1,564.17
PBDT000000
EBITDA97.57-37.3%222.89307.3477.13155.54574.51
Depreciation-28.77-26.56-25.09-23.92-22.54-91.74
EBIT68.80-48.3%196.33282.2553.21133482.77
PBT68.98-46.7%197.85287.4954.48129.44488.98
Tax-17.35-50.17-74.82-13.90-32.58-124.98
Equity12.9012.9012.900012.90
OPM15.0930.4436.4512.1725.0823.82
Net Profit51.63-46.7%147.67212.6740.5796.85364
NPM11.2922.7226.969.0618.7717.73
EPS40.24-46.7%115.10165.7631.6275.49283.71

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,022.99+37.0%1,476.84-5.2%1,558.58+30.8%1,191.20+25.2%951.08+1.5%936.91
Other Income30.1720.5112.549.752.0816.10
Total Income2,053.15+37.1%1,497.35-4.7%1,571.13+30.8%1,200.95+26.0%953.15+0.0%953.01
Expenditure-1,564.17-27.4%-1,227.42-4.9%-1,169.69-18.7%-985.20-13.1%-870.99-2.7%-847.68
Interest-23.95-8.30-14-13.07-13.50-17.90
PBDT000000
EBITDA574.51+77.7%323.27-30.1%462.59+70.2%271.85+90.6%142.63-2.8%146.81
Depreciation-91.74-65.55-59.70-52.78-49.04-39.68
EBIT482.77+87.3%257.72-36.0%402.89+83.9%219.07+134.1%93.59-12.6%107.13
PBT488.98+41.2%346.33-13.7%401.44+86.1%215.75+162.6%82.16-22.0%105.33
Tax-124.98-86.22-101.36-52.23-18.34-24.70
Equity12.9012.900000
OPM (%)23.8223.1325.5517.968.6211.05
Net Profit364+39.9%260.11-13.3%300.08+83.5%163.52+156.2%63.82-20.8%80.63
NPM (%)17.7317.3719.1013.626.708.46
EPS (Rs)283.71+39.9%202.74-13.3%233.89+83.5%127.45+156.2%49.74-20.9%62.85
CEPS283.71202.74233.89127.4549.7462.85

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

16
YearTypeAmountEx-Date
2026Final Dividend3424 Jul 2026
2025Final Dividend1218 Jul 2025
2024Final Dividend1412 Jul 2024
2023Final Dividend1011 Jul 2023
2022Final Dividend514 Jul 2022
2021Final Dividend329 Jun 2021
2021Interim Dividend210 Nov 2020
2020Interim Dividend218 Feb 2020
2019Final Dividend1.227 Jun 2019
2016Final Dividend204 Aug 2016
2015Final Dividend1.506 Aug 2015
2014Final Dividend1.516 Jun 2014
2014Special Dividend1.516 Jun 2014
2013Final Dividend1.224 Jul 2013
2009Final Dividend3.513 Jul 2009
2008Final Dividend2.517 Jul 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers